144.31新台幣1.36(0.95%)
2023/02/02更新
績效 / 1月6.09%
3月20.73%
1年
晨星評等-
淨值走勢
基金總覽
基金規模4,560.82百萬截至 2022-12-31
持股明細 / 風險評估
- 1.已開發亞洲83.29%
- 2.新興亞洲3.96%
- 3.美國0.85%
- 1.科技29.42%
- 2.健康護理28.96%
- 3.周期性消費19.20%
- 4.工業6.10%
- 5.公用2.05%
- 1.Bora Pharmaceuticals Co Ltd7.28%
- 2.PharmaEngine Inc4.93%
- 3.EirGenix Inc4.85%
- 4.Oneness Biotech Co Ltd4.84%
- 5.Poya International Co Ltd4.36%
- 1.已開發亞洲83.29%
- 2.新興亞洲3.96%
- 3.美國0.85%
- 1.Bora Pharmaceuticals Co Ltd7.28%
- 2.PharmaEngine Inc4.93%
- 3.EirGenix Inc4.85%
- 4.Oneness Biotech Co Ltd4.84%
- 5.Poya International Co Ltd4.36%
- 1.科技29.42%
- 2.健康護理28.96%
- 3.周期性消費19.20%
- 4.工業6.10%
- 5.公用2.05%